158 related articles for article (PubMed ID: 11775905)
1. [Microsatellite instability in endometrial neoplasms correlation with clinicopathologic parameters and estrogen receptor or progesterone receptor status].
Song Y; Lang J
Zhonghua Fu Chan Ke Za Zhi; 2000 May; 35(5):273-6. PubMed ID: 11775905
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
[TBL] [Abstract][Full Text] [Related]
3. Microsatellite instability in endometrial cancer: relation to histological subtypes.
Tibiletti MG; Furlan D; Taborelli M; Facco C; Riva C; Franchi M; Cossu A; Trubia M; Taramelli R; Capella C
Gynecol Oncol; 1999 May; 73(2):247-52. PubMed ID: 10329042
[TBL] [Abstract][Full Text] [Related]
4. Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma.
Caduff RF; Johnston CM; Svoboda-Newman SM; Poy EL; Merajver SD; Frank TS
Am J Pathol; 1996 May; 148(5):1671-8. PubMed ID: 8623934
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H
Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591
[TBL] [Abstract][Full Text] [Related]
6. Microsatellite alterations on human chromosome 11 in in situ and invasive breast cancer: a microdissection microsatellite analysis and correlation with p53, ER (estrogen receptor), and PR (progesterone receptor) protein immunoreactivity.
Shen KL; Yang LS; Hsieh HF; Chen CJ; Yu JC; Tsai NM; Harn HJ
J Surg Oncol; 2000 Jun; 74(2):100-7. PubMed ID: 10914818
[TBL] [Abstract][Full Text] [Related]
7. [Estrogen and progesterone receptors in endometrial carcinoma].
Guo Y; Dang Q
Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):418-21. PubMed ID: 9639729
[TBL] [Abstract][Full Text] [Related]
8. Epithelial and stromal estrogen and progesterone receptor expression in endometrial cancer: true color computer-assisted image analysis versus subjective scoring.
Kohlberger PD; Kieback DG; Breitenecker F; Loesch A; Gitsch G; Kainz C; Breitenecker G
Gynecol Oncol; 1997 Mar; 64(3):404-10. PubMed ID: 9062141
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
Suthipintawong C; Wejaranayang C; Vipupinyo C
J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
[TBL] [Abstract][Full Text] [Related]
10. [Study on expression of PCNA and estrogen, progesterone receptors in endometrial carcinoma].
Chen YP; Shen M; Chen C
Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):123-5. PubMed ID: 12536641
[TBL] [Abstract][Full Text] [Related]
11. Microsatellite instability correlates with negative expression of estrogen and progesterone receptors in sporadic breast cancer.
Caldés T; Perez-Segura P; Tosar A; de La Hoya M; Diaz-Rubio E
Teratog Carcinog Mutagen; 2000; 20(5):283-91. PubMed ID: 10992275
[TBL] [Abstract][Full Text] [Related]
12. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
[TBL] [Abstract][Full Text] [Related]
13. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.
Lax SF; Kurman RJ
Verh Dtsch Ges Pathol; 1997; 81():228-32. PubMed ID: 9474874
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite instability and somatic mutations in endometrial carcinomas.
Sakamoto T; Murase T; Urushibata H; Kato K; Takada H; Imamura T; Mori H; Wake N
Gynecol Oncol; 1998 Oct; 71(1):53-8. PubMed ID: 9784319
[TBL] [Abstract][Full Text] [Related]
15. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer.
Ferrandina G; Ranelletti FO; Gallotta V; Martinelli E; Zannoni GF; Gessi M; Scambia G
Gynecol Oncol; 2005 Sep; 98(3):383-9. PubMed ID: 15979129
[TBL] [Abstract][Full Text] [Related]
16. The expression analysis of the estrogen and progesterone receptors in endometrial carcinomas.
Olech-Fudali E; Chibowski D; Skomra D; Walczyna B
Ann Univ Mariae Curie Sklodowska Med; 2001; 56():319-25. PubMed ID: 11977333
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between receptor status and results of treatment in endometrial carcinoma].
Baĭnazarova AA; Iskakova ZhK
Vopr Onkol; 2006; 52(6):654-8. PubMed ID: 17338243
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability is correlated with lymph node-positive breast cancer.
De Marchis L; Contegiacomo A; D'Amico C; Palmirotta R; Pizzi C; Ottini L; Mastranzo P; Figliolini M; Petrella G; Amanti C; Battista P; Bianco AR; Frati L; Cama A; Mariani-Costantini R
Clin Cancer Res; 1997 Feb; 3(2):241-8. PubMed ID: 9815679
[TBL] [Abstract][Full Text] [Related]
20. Lactoferrin immunoexpression in endometrial carcinomas: relationships with sex steroid hormone receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and survival.
Giuffrè G; Arena F; Scarfì R; Simone A; Todaro P; Tuccari G
Oncol Rep; 2006 Aug; 16(2):257-63. PubMed ID: 16820900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
